Talking the Cure with Hogan Lovells  By  cover art

Talking the Cure with Hogan Lovells

By: Hogan Lovells
  • Summary

  • Hogan Lovells is always thinking about how to conquer and foresee the most significant industry issues facing our clients. If you’ve been following us for the past two years, you’ve heard first-hand from our lawyers around the world on significant developments in the Life Sciences & Health Care sector and why they are so passionate about the industry. In season 3, we’ll unpack new and exciting industry trends and bring you more outside perspectives to keep you ahead of the curve.
    Hogan Lovells
    Show more Show less
Episodes
  • Talking the Cure - Exploring the industry with Alice Valder Curran
    Nov 16 2023
    In this episode, Alice Valder Curran sits down with us to talk about her impressive career, why she ultimately chose Hogan Lovells as her employer, and what it takes to be successful in this area of the industry, even in times when you can only work part-time. Alice gives us a behind-the-scenes look at how to create your own niche and surround yourself with people who have the same standards for themselves and the same sense of quality.
    Show more Show less
    39 mins
  • Talking the Cure - Exploring the industry with Randy Prebula
    Oct 23 2023
    In this episode, Randy Prebular sits down with us and we talk about his impressive professional career, how he actually wanted to be a pediatrician at the beginning of his career, and how he then went from being a research scientist to a partner in a major law firm. We hear many exciting anecdotes, Randy gives us a behind-the-scenes look and tips on how young lawyers can make their careers more successful.
    Show more Show less
    46 mins
  • Talking the Cure - Discussing the implications of the Inflation Reduction Act (IRA)
    Sep 28 2023
    In this podcast episode, Alice Curran and Cullen Taylor discuss the implications of the Inflation Reduction Act (IRA) on the life sciences and healthcare sector. They explore how IRA can impact drug pricing, development, collaboration, and partnerships. The episode covers assessing IRA’s impact, economic provisions in agreements, launch strategies, backup compounds, fixed-dose combinations, and the challenges of out-licensing. They highlight the complexities and potential risks in dealing with IRA.
    Show more Show less
    31 mins

What listeners say about Talking the Cure with Hogan Lovells

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.